Pura Vida Investments is a fundamentally driven, market neutral healthcare-focused investment vehicle. The objective of the firm is to identify and capitalize on structural changes in the healthcare landscape and on inflections in company specific valuations. The firm strives to look past day-to-day volatility and to hone in on major value shifts
over the medium to longer term.
The firm’s portfolio is managed by Efrem Kamen and Doron Junger MD and is run in a market neutral fashion, investing across most areas of healthcare, including medical devices, biotechnology, pharmaceuticals, tools, life sciences and healthcare services. The Fund has an optional 10% allocation to designated investments, allowing participation in private and certain illiquid public securities, which is managed by Frank Litvack MD.
Website:www.puravidainvestments.com
Industries:
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Wellness
Medical
Medical Device
Diabetes
Agriculture
Chemical
Food Processing
Life Science
Manufacturing
Artificial Intelligence
Machine Learning
Health Diagnostics
Personal Health
Biopharma
Genetics
Cannabis
Consumer Goods
Packaging Services
Clinical Trials
Home Health Care
Investor Types:
Venture Capital
Investment Stages:
Location:
New York City, New York, United States
Contact information:
